CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Roche Holding AG (Participation) - ROGz CFD

    253.2
    1.65%
    1.1
    Low: 249.2
    High: 253.5
    Market Trading Hours* (UTC) Opens on Monday at 08:00

    Mon - Fri: 08:00 - 16:20

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 1.1
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.015657 %
    Charges from full value of position ($-2.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.015657%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.006565 %
    Charges from full value of position ($-1.25)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.006565%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency CHF
    Margin 5%
    Stock exchange Switzerland
    Commission on trade 0%

    *Information provided by Capital.com

    Roche Holding AG ESG Risk Ratings

    High Medium Low Negligible

    ‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

    More ESG coverage

    Key Stats
    Prev. Close* 249.1
    Open* 249.2
    1-Year Change* -17.48%
    Day's Range* 249.2 - 253.5
    52 wk Range 230.90-314.25
    Average Volume (10 days) 1.18M
    Average Volume (3 months) 27.02M
    Market Cap 192.84B
    P/E Ratio 17.27
    Shares Outstanding 798.65M
    Revenue 60.77B
    EPS 13.70
    Dividend (Yield %) 4.01522
    Beta 0.75
    Next Earnings Date Feb 1, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 7, 2023 249.1 -1.7 -0.68% 250.8 251.6 248.7
    Dec 6, 2023 249.9 0.6 0.24% 249.3 251.1 246.6
    Dec 5, 2023 250.8 3.4 1.37% 247.4 251.7 245.9
    Dec 4, 2023 246.1 5.3 2.20% 240.8 246.4 240.8
    Dec 1, 2023 238.8 4.0 1.70% 234.8 239.8 234.7
    Nov 30, 2023 237.3 1.5 0.64% 235.8 237.6 234.0
    Nov 29, 2023 235.7 0.3 0.13% 235.4 237.4 234.9
    Nov 28, 2023 235.6 0.1 0.04% 235.5 235.8 232.7
    Nov 27, 2023 237.1 -1.5 -0.63% 238.6 238.8 236.6
    Nov 24, 2023 238.5 -0.1 -0.04% 238.6 239.3 238.0
    Nov 23, 2023 238.4 2.2 0.93% 236.2 238.5 236.0
    Nov 22, 2023 236.5 0.3 0.13% 236.2 237.7 236.0
    Nov 21, 2023 236.9 0.4 0.17% 236.5 237.2 235.6
    Nov 20, 2023 237.3 0.6 0.25% 236.7 237.4 234.6
    Nov 17, 2023 237.4 0.4 0.17% 237.0 238.1 236.2
    Nov 16, 2023 236.8 -0.5 -0.21% 237.3 238.5 236.2
    Nov 15, 2023 237.7 -1.6 -0.67% 239.3 241.4 236.6
    Nov 14, 2023 238.4 -0.5 -0.21% 238.9 239.9 237.5
    Nov 13, 2023 238.0 1.4 0.59% 236.6 239.1 235.2
    Nov 10, 2023 236.2 -0.9 -0.38% 237.1 239.2 235.2

    Roche Holding AG (Participation) Events

    Time (UTC) Country Event
    Tuesday, December 12, 2023

    Time (UTC)

    07:00

    Country

    CH

    Event

    Roche Holding AG at Exane BNPP DILS CEO Conference (Virtual)
    Roche Holding AG at Exane BNPP DILS CEO Conference (Virtual)

    Forecast

    -

    Previous

    -

    Time (UTC)

    17:00

    Country

    CH

    Event

    Roche Holding AG ASH Virtual Event
    Roche Holding AG ASH Virtual Event

    Forecast

    -

    Previous

    -
    Wednesday, January 31, 2024

    Time (UTC)

    06:00

    Country

    CH

    Event

    Full Year 2023 Roche Holding AG Earnings Release
    Full Year 2023 Roche Holding AG Earnings Release

    Forecast

    -

    Previous

    -
    Wednesday, March 13, 2024

    Time (UTC)

    09:30

    Country

    CH

    Event

    Roche Holding AG Annual Shareholders Meeting
    Roche Holding AG Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 63281 62801 58323 61466 56846
    Revenue 63281 62801 58323 61466 56846
    Cost of Revenue, Total 18511 19348 15900 17377 16445
    Gross Profit 44770 43453 42423 44089 40401
    Total Operating Expense 45805 44646 39780 43918 42077
    Selling/General/Admin. Expenses, Total 12124 12100 12075 13208 12453
    Research & Development 14050 13707 12151 11690 11048
    Depreciation / Amortization 378 351 446 268 183
    Unusual Expense (Income) 2569 376 426 2677 3945
    Other Operating Expenses, Total -1827 -1236 -1218 -1302 -1997
    Operating Income 17476 18155 18543 17548 14769
    Interest Income (Expense), Net Non-Operating -1040 -677 -463 -758 -419
    Other, Net -109 -80 -115 -176 -202
    Net Income Before Taxes 16327 17398 17965 16614 14148
    Net Income After Taxes 13531 14935 15068 14108 10830
    Minority Interest -1110 -1005 -773 -611 -365
    Net Income Before Extra. Items 12421 13930 14295 13497 10465
    Net Income 12421 13930 14295 13497 10500
    Income Available to Common Excl. Extra. Items 12421 13930 14295 13497 10465
    Income Available to Common Incl. Extra. Items 12421 13930 14295 13497 10500
    Dilution Adjustment -1 -1 -1 -2 -1
    Diluted Net Income 12420 13929 14294 13495 10499
    Diluted Weighted Average Shares 808 860 865 864 860
    Diluted EPS Excluding Extraordinary Items 15.3713 16.1965 16.5249 15.6192 12.1674
    Dividends per Share - Common Stock Primary Issue 9.5 9.3 9.1 9 8.7
    Diluted Normalized EPS 17.9847 16.5778 16.9515 18.2807 15.702
    Total Extraordinary Items 35
    Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
    Total revenue 29779 30986 32295 32088 30713
    Revenue 29779 30986 32295 32088 30713
    Cost of Revenue, Total 7619 8949 9562 10279 9069
    Gross Profit 22160 22037 22733 21809 21644
    Total Operating Expense 20015 25057 20748 24010 20636
    Selling/General/Admin. Expenses, Total 6505 6479 5645 6544 5556
    Research & Development 6449 7422 6628 7017 6690
    Depreciation / Amortization 170 196 182 177 174
    Unusual Expense (Income) 814 2584 -15 619 -243
    Other Operating Expenses, Total -1542 -573 -1254 -626 -610
    Operating Income 9764 5929 11547 8078 10077
    Interest Income (Expense), Net Non-Operating -500 -568 -472 -524 -151
    Other, Net -90 -19 -90 -43 -39
    Net Income Before Taxes 9174 5342 10985 7511 9887
    Net Income After Taxes 7563 4370 9161 6719 8216
    Minority Interest -426 -479 -631 -592 -413
    Net Income Before Extra. Items 7137 3891 8530 6127 7803
    Net Income 7137 3891 8530 6127 7803
    Income Available to Common Excl. Extra. Items 7137 3891 8530 6127 7803
    Income Available to Common Incl. Extra. Items 7137 3891 8530 6127 7803
    Dilution Adjustment 0 -1 0 -1 0
    Diluted Net Income 7137 3890 8530 6126 7803
    Diluted Weighted Average Shares 804 806 810 858 862
    Diluted EPS Excluding Extraordinary Items 8.87687 4.8263 10.5309 7.13986 9.0522
    Dividends per Share - Common Stock Primary Issue 0 9.5 0 9.3 0
    Diluted Normalized EPS 9.73715 7.42355 10.5195 7.78732 8.8218
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 33816 35627 32942 31254 32244
    Cash and Short Term Investments 9767 13031 12334 11858 13118
    Cash 2841 5028 4536 4769 4139
    Cash & Equivalents 2150 1822 1191 1306 2542
    Short Term Investments 4776 6181 6607 5783 6437
    Total Receivables, Net 13866 12651 11740 12150 11487
    Accounts Receivable - Trade, Net 11527 10719 10056 10343 9687
    Total Inventory 8605 7715 7194 6055 6621
    Prepaid Expenses 1202 1869 1153 795 683
    Other Current Assets, Total 376 361 521 396 335
    Total Assets 88151 92317 86138 83091 78517
    Property/Plant/Equipment, Total - Net 24208 24412 23270 23318 21818
    Property/Plant/Equipment, Total - Gross 49408 48205 45664 45041 41822
    Accumulated Depreciation, Total -25200 -23793 -22394 -21723 -20004
    Goodwill, Net 10820 10809 9249 12456 8948
    Intangibles, Net 9685 12117 12017 8358 9346
    Long Term Investments 971 1069 1276 739 602
    Note Receivable - Long Term 125 133 125 128 132
    Other Long Term Assets, Total 8526 8150 7259 6838 5427
    Total Current Liabilities 27239 38416 25401 24119 23033
    Accounts Payable 3861 3844 3317 3176 2847
    Accrued Expenses 12180 12497 11205 11214 10676
    Notes Payable/Short Term Debt 2191 14618 2189 1694 722
    Current Port. of LT Debt/Capital Leases 2071 833 2126 341 1971
    Other Current Liabilities, Total 6936 6624 6564 7694 6817
    Total Liabilities 60159 67828 49797 50344 50895
    Total Long Term Debt 22282 17101 11096 13547 16077
    Long Term Debt 21391 16076 10220 12668 16075
    Capital Lease Obligations 891 1025 876 879 2
    Deferred Income Tax 645 628 353 298 384
    Minority Interest 4023 3856 3432 3120 2744
    Other Liabilities, Total 5970 7827 9515 9260 8657
    Total Equity 27992 24489 36341 32747 27622
    Common Stock 107 160 160 160 160
    Retained Earnings (Accumulated Deficit) 38937 34161 45571 40524 34935
    Unrealized Gain (Loss) -59 -60 106 15 28
    Other Equity, Total -10993 -9772 -9496 -7952 -7501
    Total Liabilities & Shareholders’ Equity 88151 92317 86138 83091 78517
    Total Common Shares Outstanding 799.181 800.403 853.126 855.756 854.428
    Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
    Total Current Assets 30976 33816 30321 35627 31260
    Cash and Short Term Investments 7509 9767 6808 13031 8017
    Cash & Equivalents 3720 4991 4315 6850 5000
    Short Term Investments 3789 4776 2493 6181 3017
    Total Receivables, Net 11359 11919 11078 11126 11809
    Accounts Receivable - Trade, Net 11089 11606 10809 10806 11656
    Total Inventory 8496 8605 8292 7715 8319
    Other Current Assets, Total 3612 3525 4143 3755 3115
    Total Assets 84370 88151 86736 92317 87887
    Property/Plant/Equipment, Total - Net 23895 24208 24324 24412 24300
    Goodwill, Net 10564 10820 11160 10809 10623
    Intangibles, Net 9129 9685 11735 12117 12510
    Other Long Term Assets, Total 9806 9622 9196 9352 9194
    Total Current Liabilities 26208 27239 27409 38416 25193
    Payable/Accrued 4055 4556 3896 4637 4241
    Notes Payable/Short Term Debt 2060 2191 2976 14618 2530
    Current Port. of LT Debt/Capital Leases 2981 1769 2405 504 1196
    Other Current Liabilities, Total 17112 18723 18132 18657 17226
    Total Liabilities 57855 60159 61547 67828 50073
    Total Long Term Debt 20345 21391 22369 16076 11285
    Long Term Debt 20345 21391 22369 16076 11285
    Deferred Income Tax 671 645 690 628 499
    Minority Interest 3829 4023 3757 3856 3619
    Other Liabilities, Total 6802 6861 7322 8852 9477
    Total Equity 26515 27992 25189 24489 37814
    Common Stock 107 107 107 160 160
    Retained Earnings (Accumulated Deficit) 38333 38937 35740 34161 46686
    Unrealized Gain (Loss) -72 -59 -151 -60 -90
    Other Equity, Total -11853 -10993 -10507 -9772 -8942
    Total Liabilities & Shareholders’ Equity 84370 88151 86736 92317 87887
    Total Common Shares Outstanding 798.652 799.181 800.579 800.403 854.261
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 13531 14935 15068 14108 10865
    Cash From Operating Activities 18415 20976 18566 22385 19979
    Cash From Operating Activities 2906 2887 2808 2760 2292
    Amortization 938 1556 1750 1532 1294
    Non-Cash Items 9267 7718 6227 8883 10308
    Cash Taxes Paid 4102 3343 3236 3543 3288
    Cash Interest Paid 557 407 422 624 593
    Changes in Working Capital -8227 -6120 -7287 -4898 -4780
    Cash From Investing Activities -3536 -6552 -9067 -8634 -7195
    Capital Expenditures -4797 -4652 -7858 -4896 -6746
    Other Investing Cash Flow Items, Total 1261 -1900 -1209 -3738 -449
    Cash From Financing Activities -16275 -13108 -9666 -14173 -10691
    Financing Cash Flow Items -2340 -2333 -1992 -1716 -3316
    Total Cash Dividends Paid -7832 -8132 -7964 -7682 -7253
    Issuance (Retirement) of Debt, Net -6103 16348 290 -4775 -122
    Foreign Exchange Effects -463 -193 -181 -184 -131
    Net Change in Cash -1859 1123 -348 -606 1962
    Issuance (Retirement) of Stock, Net 0 -18991
    Dec 2022 Jun 2022 Dec 2021 Jun 2021
    Net income/Starting Line 13531 9161 14935 8216
    Cash From Operating Activities 18415 9509 20976 8212
    Cash From Operating Activities 2906 1429 2887 1439
    Amortization 938 471 1556 830
    Non-Cash Items 9267 3799 7718 3323
    Cash Taxes Paid 4102 2482 3343 2183
    Cash Interest Paid 557 228 407 243
    Changes in Working Capital -8227 -5351 -6120 -5596
    Cash From Investing Activities -3536 1473 -6552 44
    Capital Expenditures -4797 -2067 -4652 -2197
    Other Investing Cash Flow Items, Total 1261 3540 -1900 2241
    Cash From Financing Activities -16275 -13315 -13108 -9056
    Financing Cash Flow Items -2340 -1374 -2333 -1211
    Total Cash Dividends Paid -7832 -7672 -8132 -7955
    Issuance (Retirement) of Debt, Net -6103 -4269 16348 110
    Foreign Exchange Effects -463 -202 -193 73
    Net Change in Cash -1859 -2535 1123 -727
    Issuance (Retirement) of Stock, Net 0 -18991
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.1844 22372151 50541 2023-09-30 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.8532 20045265 2208289 2022-12-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.847 12976127 39742 2023-09-30 LOW
    UBS Asset Management (Switzerland) Investment Advisor 1.8359 12898101 25826 2023-09-30 LOW
    Credit Suisse Funds AG Investment Advisor/Hedge Fund 1.6299 11450926 69518 2023-09-30 LOW
    MFS Investment Management Investment Advisor/Hedge Fund 1.5735 11055080 62048 2023-09-30 LOW
    Zürcher Kantonalbank (Asset Management) Bank and Trust 1.3184 9262276 -48615 2023-09-30 LOW
    BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.9311 6541705 303560 2023-09-30 LOW
    Fidelity International Investment Advisor 0.8825 6199852 -14057 2023-09-30 LOW
    DWS Investment GmbH Investment Advisor/Hedge Fund 0.6625 4654632 20709 2023-09-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.6344 4457325 1131 2023-09-30 LOW
    Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 0.6078 4269826 -124448 2023-06-30 LOW
    Dodge & Cox Investment Advisor/Hedge Fund 0.5978 4200100 -5500 2023-09-30 LOW
    California Public Employees' Retirement System Pension Fund 0.5839 4102151 -453583 2022-06-30 LOW
    Fidelity Management & Research Company LLC Investment Advisor 0.5124 3599675 -253068 2023-08-31 LOW
    BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.4875 3424807 0 2023-09-30 LOW
    Flossbach von Storch AG Investment Advisor 0.4388 3082720 5931 2023-06-30 LOW
    Capital Research Global Investors Investment Advisor 0.3727 2618264 416387 2023-09-30 LOW
    Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.3639 2556472 -580953 2023-09-30 LOW
    Mawer Investment Management Ltd. Investment Advisor 0.3514 2468913 103 2023-09-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Roche Company profile

    About Roche Holding AG

    Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Roche Holding AG revenues increased 8% to SF62.8B. Net income decreased 3% to SF13.93B. Revenues reflect Diagnostics segment increase of 29% to SF17.76B, Chugai segment increase of 20% to SF4.51B, Rest of Europe segment increase of 16% to SF11.38B, Rest of Asia segment increase of 13% to SF9.75B, Germany segment increase of 29% to SF4.29B.

    Equity composition

    3 April 2001, 100 for 1 stock split.

    Industry: Pharmaceuticals (NEC)

    Grenzacherstrasse 124
    BASEL
    BASEL-STADT 4058
    CH

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    Oil - Crude

    71.33 Price
    +2.190% 1D Chg, %
    Long position overnight fee -0.0212%
    Short position overnight fee -0.0007%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    US100

    16,075.30 Price
    +0.460% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Gold

    1,999.81 Price
    -1.370% 1D Chg, %
    Long position overnight fee -0.0198%
    Short position overnight fee 0.0116%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    BTC/USD

    43,883.95 Price
    +1.030% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading